As of February, 7 The EPS for IDEXX Laboratories, Inc. (IDXX) Expected At $0.90

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Corporate Logo
During 2018 Q3 the big money sentiment increased to 1.04. That’s change of 0.03, from 2018Q2’s 1.01. 25 investors sold all, 207 reduced holdings as IDEXX Laboratories, Inc. ratio increased. 159 rose positions while 82 funds took positions. Funds hold 70.63 million shares thus 1.73% less from 2018Q2’s 71.88 million shares.
Arrowstreet Cap Ltd Partnership has 962,556 shs. Nuveen Asset Mngmt Ltd Liability reported 2,223 shs. 6,187 are owned by Janney Montgomery Scott Ltd Liability. Landscape Cap Mngmt Limited Company reported 0.02% stake. Susquehanna Intll Grp Limited Liability Partnership holds 0% or 10,107 shs in its capital. Highstreet Asset Management holds 0.06% in IDEXX Laboratories, Inc. (NASDAQ:IDXX) or 4,192 shs. Invesco Limited has invested 0.1% of its capital in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Tokio Marine Asset Mngmt accumulated 0.12% or 2,655 shs. Acg Wealth reported 15,696 shs. Morgan Stanley holds 0.03% of its capital in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 439,913 shs. Twin Tree Lp invested 0.01% of its capital in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Caprock Grp Inc accumulated 929 shs. Mitsubishi Ufj Secs invested in 370 shs. Wetherby Asset Mgmt reported 0.05% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Fcg Advsr Lc owns 2,538 shs for 0.22% of their capital.

IDEXX Laboratories, Inc. had 6 selling transactions and 0 insider buys since August 21, 2018. This’s net activity of $15.75 million. Studer Jacqueline had sold 11,619 shs worth $2.84M. AYERS JONATHAN W had sold 30,000 shs worth $7.37M on Tuesday, August 21. 11,372 shs were sold by TWIGGE GIOVANI, worth $2.76 million on Tuesday, August 21. $1.44 million worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) shs were sold by Lane Michael.

IDEXX Laboratories, Inc. (NASDAQ:IDXX)’s earnings report is awaited on February, 7., Zacks reports. Analysts predict $0.90 earnings per share. That’s $0.13 up or 16.88 % from 2018’s earnings of $0.77. If reported the P/E will be 53.59 with $77.61M profit. Wall Street sees -14.29 % negative EPS growth as of February, 7. The stock increased 0.10% or $0.19 during the last trading session, touching $192.91.IDEXX Laboratories, Inc. has volume of 282,843 shares. Since January 12, 2018 IDXX has risen 22.67% and is uptrending. IDXX outperformed the S&P500 by 22.67%.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Ratings Coverage

Total analysts of 3 have positions in IDEXX Laboratories (NASDAQ:IDXX) as follows: 3 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since August 17, 2018 according to StockzIntelligence Inc IDEXX Laboratories has 3 analyst reports. On Friday, November 2 the firm earned “Buy” rating by Bank of America. The company rating was maintained by Credit Suisse on Friday, August 17. On Monday, November 5 the stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Buy” rating by Canaccord Genuity.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, makes, and distributes services and products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.The firm is worth $16.64 billion. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other divisions.The P/E ratio is 51.91. The firm provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

For more IDEXX Laboratories, Inc. (NASDAQ:IDXX) news brought out briefly go to: Seekingalpha.com, Globenewswire.com, Nasdaq.com, Seekingalpha.com or Fool.com. The titles are as follows: “IDEXX: This Medical Equipment Stock Is Overvalued And Could Go Down As Much As 20% – Seeking Alpha” brought out on May 18, 2018, “Analysis: Positioning to Benefit within IDEXX Laboratories, Editas Medicine, Arconic, Cardtronics, Cloudera, and BMC Stock — Research Highlights Growth, Revenue, and Consolidated Results – GlobeNewswire” on November 12, 2018, “Can CAG Growth for IDEXX (IDXX) Stock Return in Q1 Earnings? – Nasdaq” with a publish date: April 24, 2018, “Canaccord bullish on medical diagnostic firms – Seeking Alpha” and the last “IDEXX Laboratories Inc (IDXX) Q3 2018 Earnings Conference Call Transcript – Motley Fool” with publication date: November 01, 2018.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.